Does ischemic preconditioning afford clinically relevant cardioprotection?

American Journal of Cardiovascular Drugs

Volumn 3, Issue 1, 2003, Pages 1-11

  Mikhail, Peter ^a   Verma, Subodh ^a   Fedak, Paul W M ^a   Weisel, Richard D ^a   Li, Ren Ke ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 4,5 DIMETHYL 3 (3 TRIFLUOROMETHYLBENZOYL)THIOPHENE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; AMINOPHYLLINE; BAMIFYLLINE; BIMAKALIM; BIOLOGICAL MARKER; BRADYKININ; BRADYKININ B2 RECEPTOR; DIPYRIDAMOLE; GLIBENCLAMIDE; GLIMEPIRIDE; HEART ENZYME; ISOFLURANE; ISOSORBIDE DINITRATE; LIDOCAINE; MORPHINE; NALOXONE; NICORANDIL; OPIATE; OPIATE AGONIST; OPIATE RECEPTOR; PHOSPHOLIPASE D; PHOSPHOTRANSFERASE; PLACEBO; POTASSIUM; POTASSIUM CHANNEL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; UNINDEXED DRUG;

CHANNEL GATING; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERANCE; ENZYME RELEASE; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; OPEN HEART SURGERY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CARDIOTONIC AGENTS; CLINICAL TRIALS; CORONARY STENOSIS; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION;

EID: 0037286752     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200303010-00001     Document Type: Review

References (65)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986 Nov; 74 (5): 1124-36
2. Napoli C, Pinto A, Cirino G. Pharmacological modulation, preclinical studies, and new clinical features of myocardial ischemic preconditioning. Pharmacol Ther 2000 Dec; 88 (3): 311-31
3. Ikonomidis JS, Shirai T, Weisel RD, et al. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am J Physiol 1997 Mar; 272 (3 Pt 2): H1220-30
4. Yao Z, Mizumura T, Mei DA, et al. KATP channels and memory of ischemic preconditioning in dogs: synergism between adenosine and KATP channels. Am J Physiol 1997 Jan; 272 (1 Pt 2): H334-42
5. Mizumura T, Auchampach JA, Linden J, et al. PD 81,723, an allosteric enhancer of the A1 adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ Res 1996 Sep; 79 (3): 415-23
6. Sheldrick A, Gray M Drew GM, et al. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol 1999 Sep; 128 (2): 385-95
7. Hill RJ, Oleynek JJ, Magee W, et al. Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart. J Mol Cell Cardiol 1998 Mar; 30 (3): 579-85
8. Baxter GF, Mather MS, Patel VC, et al. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic, preconditioning. Circulation 1994 Dec; 90 (6): 2993-3000
9. Schultz JE, Rose E, Yao Z, et al. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol 1995 May; 268 (5 Pt 2): H2157-61
10. Schultz JJ, Hsu AK, Gross GJ. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 1997 Aug; 29 (8): 2187-95
11. Schultz JE, Hsu AK, Gross GJ. Ischemic preconditioning in the intact rat heart is mediated by delta1- but not mu- or kappa-opioid receptors. Circulation 1998 Apr 7; 97 (13): 1282-9
12. Schultz JE, Hsu AK, Barbieri JT, et al. Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am J Physiol 1998 Aug; 275 (2 Pt 2): H495-500
13. Miki T, Miura T, Ura N, et al. Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation. J Am Coll Cardiol 1996 Nov 15; 28 (6): 1616-22
14. Yang XP, Liu YH, Scicli GM, et al. Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats. Hypertension 1997 Sep; 30 (3 Pt 2): 735-40
15. Kita H, Miura T, Miki T, et al. Infarct size limitation by bradykinin receptor activation is mediated by the mitochondrial but not by the sarcolemmal K (ATP) channel. Cardiovasc Drugs Ther 2000 Oct; 14 (5): 497-502
16. Armstrong S, Downey JM, Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res 1994 Jan; 28 (1): 72-7
17. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994 Mar; 266 (3 Pt 2): H1145-52
18. Ikonomidis JS, Shirai T, Weisel RD, et al. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am J Physiol 1997 Mar; 272 (3 Pt 2): H1220-30
19. Maulik N, Watanabe M, Zu YL, et al. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 1996 Nov 4; 396 (2-3): 233-7
20. Imagawa Ji, Baxter GF, Yellon DM. Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48h after ischemic preconditioning in the rabbit. J Mol Cell Cardiol 1997 Jul; 29 (7): 1885-93
21. Fryer RM, Schultz JE, Hsu AK, et al. Pretreatment with tyrosine kinase inhibitors partially attenuates ischemic preconditioning in rat hearts. Am J Physiol 1998 Dec; 275 (6 Pt 2): H2009-15
22. Fryer RM, Schultz JE, Hsu AK, et al. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat heafts. Am J Physiol 1999 Apr; 276 (4 Pt 2): H1229-35
23. Weinbrenner C, Liu GS, Cohen MV, et al. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 1997 Sep; 29 (9): 2383-91
24. Cohen MV, Liu Y, Liu GS, et al. Phospholipase D plays a role in ischemic preconditioning in rabbit heart. Circulation 1996 Oct 1; 94 (7): 1713-8
25. MizumuraT, Nithipatikom K, Gross GJ. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs. Circulation 1995 Sep 1; 92 (5): 1236-45
26. Carr CS, Yellon DM. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle. Basic Res Cardiol 1997 Aug; 92 (4): 252-60
27. Liu Y, Sato T, O'Rourke B, et al. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 1998 Jun 23; 97 (24): 2463-9
28. Bernardo NL, D'Angelo M, Okubo S, et al. Delayed ischemic preconditioning is mediated by opening of ATP-sensitive potassium channels in the rabbit heart. Am J Physiol 1999 Apr; 276 (4 Pt 2): H1323-30
29. Claeys MJ, Vrints CJ, Bosmans JM, et al. Aminophylline inhibits adaptation to ischaemia during angioplasty: role of adenosine in ischemic preconditioning. Eur Heart J 1996 Apr; 17 (4): 539-44
30. Tomai F, Crea F, Gaspardone A, et al. Effects of A1 adenosine receptor blockade by bamiphylline on ischemic preconditioning during coronary angioplasty. Eur Heart J 1996 Jun; 17 (6): 846-53
31. Leesar MA, Stoddard M, Ahmed M, et al. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 1997 Jun 3; 95 (11): 2500-7
32. Mehta AB, Mardikar HM, Hiregouder NS, et al. Preconditioning the human myocardium with intracoronary adenosine. Indian Heart J 1998 Jul-Aug; 50 (4): 397-401
33. Heidland UE, Heintzen MP, Michel CJ, et al. Effect of adjunctive intracoronary adenosine on myocardial ischemia, hemodynamic function and left ventricular performance during percutaneous transluminal coronary angioplasty: clinical access to ischemic preconditioning? Coron Artery Dis 2000 Jul; 11 (5): 421-8
34. Strauer BE, Heidland UE, Vogt M, et al. Protection and "preconditioning" of the human heart during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole administration. Med Klin 1995 Mar 1; 90 (3): 125-30
35. Strauer BE, Heidland UE, Heintzen MP, et al, Pharmacological myocardial protection during percutaneous transluminal coronary angioplasty by intracoronary application of dipyridamole: impact on hemodynamic function and left ventricular performance. J Am Coll Cardiol 1996 Nov. 1; 28 (5): 1119-26
36. Heidland UE, Heintzen MP, Schwartzkopff B, et al. Preconditioning during percutaneous transluminal coronary angioplasty by endogenous and exojenous adenosine. Am Heart J 2000 Nov; 140 (5): 813-20
37. Matsubara T, Minatoguchi S, Matsuo H, et al. Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease. J Am Coll Cardiol 2000 Feb; 35 (2): 345-51
38. Patel DJ, Purcell HJ, Fox KM. Cardioprotection by opening of the K (ATP) channel in unstable angina: is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization. Eur Heart J 1999 Jan; 20 (1): 51-7
39. Dargie HJ, Ford I, Fox KM, et al. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomized trial. Lancet 2002 Apr; 359: 1269-75
40. Leesar MA, Stoddard MF, Manchikalapudi S, et al. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty. J Am Coll Cardiol 1999 Sep; 34 (3): 639-50
41. Tomai F, Crea F, Gaspardone A, et al. Effects of naloxone on myocardial ischemic preconditioning in humans. J Am Coll Cardiol 1999 Jun; 33 (7): 1863-9
42. Tomai F, Crea F, Gaspardone A, et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 1994 Aug; 90 (2): 700-5
43. Klepzig H, Kober G, Matter C, et al. Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide. Eur Heart J 1999 Mar; 20 (6): 439-46
44. Laskey WK. Beneficial impact of preconditioning during PTCA on creatine kinase release. Circulation 1999 Apr 27; 99 (16): 2085-9
45. Muller DW, Topol EJ, Califf RM, et al. Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction: Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J 1990 Feb; 119 (2 Pt 1): 224-31
46. Kloner RA, Shook T, Przyklenk K, et al. Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning? Circulation 1995 Jan 1; 91 (1): 37-45
47. Garratt KN, Holmes Jr DR, Molina-Viamonte V, et al. Intravenous adenosine and lidocaine in patients with acute mycocardial infarction. Am Heart J 1998 Aug; 136 (2): 196-204
48. Marzilli M, Orsini E, Marraccini P, et al. Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation 2000 May 9; 101 (18): 2154-9
49. Alkhulaifi AM. Preconditioning the human heart. Ann R Coll Surg Engl 1997 Jan; 79 (1): 49-54
50. Jenkins DP, Pugsley WB, Alkhulaifi AM, et al. Ischaemic preconditioning reduces Troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997 Apr; 77 (4): 314-8
51. Illes RW, Swoyer KD. Prospective, randomized clinical study of ischemic preconditioning as an adjunct to intermittent cold blood cardioplegia. Ann Thorac Surg 1998 Mar; 65 (3): 748-52
52. Lu EX, Chen SX, Yuan MD, et al. Preconditioning improves myocardial preservation in patients undergoing open heart operations. Ann Thorac Surg 1997 Nov; 64 (5): 1320-4
53. Lu EX, Chen SX, Hu TH, et al. Preconditioning enhances myocardial protection in patients undergoing open heart surgery. Thorac Cardiovasc Surg 1998 Feb; 46 (1): 28-32
54. Li G, Chen S, Lu E, et al. Ischemic preconditioning improves preservation with cold blood cardioplegia in valve replacement patients. Eur J Cardiothorac Surg 1999 May; 15 (5): 653-7
55. Musumeci F, Feccia M, MacCarthy PA, et al. Prospective randomized trial of single clamp technique versus intermittent ischaemic arrest: myocardial and neurological outcome. Eur J Cardiothorac Surg 1998 Jun; 13 (6): 702-9
56. Mentzer Jr RM, Birjiniuk V, Khuri S, et al. Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg 1999 May; 229 (5): 643-9
57. Kersten JR, Schmeling TJ, Pagel PS, et al. Isoflurane mimics ischemic preconditioning via activation of K (ATP) channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997 Aug; 87 (2): 361-70
58. Tomai F, De Paulis R, Penta de Peppo A, et al. Beneficial impact of isoflurane during coronary bypass surgery on Troponin I release. G Ital Cardiol 1999 Sep; 29 (9): 1007-14
59. Penta de Peppo A, Polisca P, Tomai F, et al. Recovery of LV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 1999 Jul; 68 (1): 112-8
60. Kaukoranta PK, Lepojarvi MP, Ylitalo KV, et al. Normothermic retrograde blood cardioplegia with or without preceding ischemic preconditioning. Ann Thorac Surg 1997 May; 63 (5): 1268-74
61. Cremer J, Steinhoff G, Karck M, et al. Ischemic preconditioning prior to myocardial protection with cold blood cardioplegia in coronary surgery. Eur J Cardiothorac Surg 1997 Nov; 12 (5): 753-8
62. Cohen G, Feder-Elituv R, Iazetta J, et al. Phase 2 studies of adenosine cardioplegia. Circulation 1998 Nov 10; 98 (19 Suppl.): II225-33
63. Belhomme D, Peynet J, Florens E, et al. Is adenosine preconditioning truly cardioprotective in coronary artery bypass surgery? Ann Thorac Surg 2000 Aug; 70 (2): 590-4
64. Noda T, Minatoguchi S, Fujii K, et al. Evidence for the delayed effect in human ischemic preconditioning: prospective multicenter study for preconditioning in acute myocardial infarction. J Am Coll Cardiol 1999 Dec; 34 (7): 1966-74
65. Bilinska M, Rudnicki S, Beresewicz A. Delayed attenuation of myocardial ischemia with repeated exercise in subjects with stable angina: a possible model for the second window of protection? Basic Res Cardiol 2000 Oct; 95 (5): 418-23